The Impact of Clinical Pathway Implementation on Length of Stay and Hospital Cost: A Systematic Review

Tanjung, Herlin Putri; Nurwahyuni, Atik

doi:10.26911/the6thicph.04.65

Cited by 4 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Current results are in line with those of Crane, (2021), who found that a monitoring and guiding program for CHF patients dramatically reduced the symptoms of complications such edema, difficult of breathing, tachycardia, arrhythmia, pulmonary cognition, chest pain, and gastrointestinal difficulties. Also, the findings support those of Tanjung and Nurwahyuni (2019), who showed that clinical pathway patients experienced less complications throughout their hospital stays. Additionally, Abouzied et al (2017) investigated how the clinical care implementation affects the hospital complications faced by 60 adult patients.…”

Section: Discussionsupporting

confidence: 86%

Effects of Application of a Nurse Driven Clinical Pathway Guidelines on Selected Health Outcomes in Children with Congestive Heart Failure

Waheda

A.Zayed²,

Ghoneim³

et al. 2021

Egyptian Journal of Health Care

View full text Add to dashboard Cite

Pediatric heart failure (HF) is a complicated clinical illness that has several causes as well as common disease development pathways. The developing evidence clinical pathway will most certainly enhance the outcomes of children with HF in the future. Purpose: effects of application of a nurse driven clinical pathway guidelines on selected health outcomes in children with congestive heart failure. Design: Quasi-experimental research design. Setting: pediatric intensive care unit

show abstract

Section: Discussionsupporting

confidence: 86%

Effects of Application of a Nurse Driven Clinical Pathway Guidelines on Selected Health Outcomes in Children with Congestive Heart Failure

Waheda

A.Zayed²,

Ghoneim³

et al. 2021

Egyptian Journal of Health Care

View full text Add to dashboard Cite

show abstract

“…The result indicated that a wellthought-out transfer decision based on facts was highly important, and specific evidence-based ICU discharge criteria and recommendations for future care seem requested. Further research about an evidence-based transfer tool also seems essential (Boyd et al, 2018), for example, clinical pathways that are associated with quality aspects such as reduced in-hospital complications (Tanjung and Nurwahyuni, 2019).…”

Section: Implications For Practice And/or Future Researchmentioning

confidence: 99%

Success Factors for Quality and Safety of Intensive Care Unit Transitional Care – Listening to the Sharp End

Häggström¹,

Ingelsson²,

Sten³

et al. 2023

QIP Journal

View full text Add to dashboard Cite

Purpose: The purpose of this paper was to present success factors for increasing quality and safety of intensive care unit (ICU) transitional care as described by co-workers at the sharp end using the core values of total quality management (TQM) as a theoretical lens. Methodology/Approach: The study had a qualitative design, with data from nine interdisciplinary focus group discussions, including co-workers from the intensive care and general wards. Data were sorted into TQM core values and analysed using qualitative content analysis. Findings: Quality and safety in transfer processes requires a holistic view, avoiding silos, shared arenas for collaboration, and evidence-based methodologies and tools for safe transfers. Research Limitation/Implication: A limitation of this study is that it only portrays the challenges encountered by two hospitals during the process of transitional care in the ICU. Originality/Value of paper: By using TQM core values as a theoretical lens, we could present a usable, holistic picture of success factors and how to improve the transfer process.

show abstract

“…This results is inline with the study of Anggriani et al, 2020, the pharmaceutical policies under the JKN implementation had a profound impact on decreasing medicine procurement prices in Indonesia (Anggriani et al, 2020) Hospitals must be more prudent in managing finances under the INA-CBGs pattern, because the tariff may appear low because some treatments are not cost effective or are still unnecessary for patients, accounting for a large portion of the package's cost (Maryati, Othman, et al, 2021) The hospital also need to evaluate the implementation of CP in the cases of pareto A, especially cases with surgical procedurs. Implementation of CP can significantly reduce hospital length of stay and cost without reducing the quality of health service (Tanjung & Nurwahyuni, 2019).…”

Section: Strengths Limitationsmentioning

confidence: 99%

The Cost Difference of Hospital Rates and Indonesia Case Base Grup (Ina CBGs) Rates of Inpatient with National Health Insurance Scheme at Private Hospital

Fitri,

Sundari

2023

jika

View full text Add to dashboard Cite

Background: Universal Health Coverage (UHC) stands for the ideal that everyone should have access to high-quality healthcare without facing financial hardship. Hospitals have an important role in the implementation of the referral system with the National HeaIth Insurance scheme. The porspektif payment system allows for difference between the Hospital rates and the INA CBGs rates. The difference in costs has the potential to cause benefits or losses for hospitals and plays an important role in supporting the sustainability of the hospitals. The challenges faced by private hospitals are different from those of government hospitals. Private hospitals must self-fund all costs incurred including investment costs and operating expenses This study aimed to evaluate the difference between hospital rate and INA-CBG's rate, focus on inpatient with NHI scheme at a private hospital at Yogyakarta, identifying the cases that contributes to a common effect of cost difference and identifying the cost components that have the most impact to the dominant cost difference. Methods: We performed a retrospective quantitative research with secondary data analysis. Data was obtained from hospital billing of a Private Hospital type C at Yogyakarta, a referral hospital in Indonesia, at period of January-December 2021. The data involved of 4474 cases of inpatient with National Health Insurance Scheme. The analysis was carried out with Pareto analysis. Results: The difference between hospital rate and Ina CBGs rate of all case is 32,5 %. The pareto analysis results that there are some NHI inpatient cases contribute a common cost difference as 1389 (31% of total cases) as high-cost case. These cases contribute 80 % of total cost difference. The cost components that have the most impact to the dominant cost difference are surgical prosedurs (26,1 %) and room and acomodation cost (19,7%). Conclusions: There are cost difference in which the hospital rate is higher than the Ina CBGs rate. There are 31 % of total cases as high cost cases, for the bulk of the cost difference. Surgical procedurs, room and acomodation cost are the cost components that have the most impact to the dominant cost differences. This study support the necessary for hospitals to evaluate the cost difference of hospital rate and Ina CBGs rate periodically for improving quality and cost efficiency at hospitals

show abstract

The Impact of Clinical Pathway Implementation on Length of Stay and Hospital Cost: A Systematic Review

Cited by 4 publications

References 0 publications

Effects of Application of a Nurse Driven Clinical Pathway Guidelines on Selected Health Outcomes in Children with Congestive Heart Failure

Effects of Application of a Nurse Driven Clinical Pathway Guidelines on Selected Health Outcomes in Children with Congestive Heart Failure

Success Factors for Quality and Safety of Intensive Care Unit Transitional Care – Listening to the Sharp End

The Cost Difference of Hospital Rates and Indonesia Case Base Grup (Ina CBGs) Rates of Inpatient with National Health Insurance Scheme at Private Hospital

Contact Info

Product

Resources

About